Qualitative Analysis of Patient Decisional Needs for Medications to Treat Heart Failure

Author:

Turgeon Ricky D.12ORCID,Fernando Saranee12,Bains Marc3,Code Jillianne13,Hawkins Nathaniel M.1ORCID,Koshman Sheri4ORCID,Straatman Lynn1ORCID,Toma Mustafa1ORCID,Virani Sean A.1ORCID,MacDonald Blair J.1ORCID,Snow M. Elizabeth12ORCID

Affiliation:

1. University of British Columbia, Vancouver, BC, Canada (R.D.T., S.F., J.C., N.M.H., L.S., M.T., S.A.V., B.J.M.D., M.E.S.).

2. Centre for Advancing Health Outcomes, Vancouver, BC, Canada (R.D.T., S.F., M.E.S.).

3. The HeartLife Foundation, Vancouver, BC, Canada (M.B., J.C.).

4. Mazankowski Alberta Heart Institute and the Division of Cardiology, University of Alberta, Edmonton, AB, Canada (S.K.).

Abstract

BACKGROUND: The development of tools to support shared decision-making should be informed by patients’ decisional needs and treatment preferences, which are largely unknown for heart failure (HF) with reduced ejection fraction (HFrEF) pharmacotherapy decisions. We aimed to identify patients’ decisional needs when considering HFrEF medication options. METHODS: This was a qualitative study using semi-structured interviews. We recruited patients with HFrEF from 2 Canadian ambulatory HF clinics and clinicians from Canadian HF guideline panels, HF clinics, and Canadian HF Society membership. We identified themes through inductive thematic analysis. RESULTS: Participants included 15 patients and 12 clinicians. Six themes and associated subthemes emerged related to HFrEF pharmacotherapy decision-making: (1) patient decisional needs included lack of awareness of a choice or options, difficult decision timing and stage, information overload, and inadequate motivation, support and resources; (2) patients’ decisional conflict varied substantially, driven by unclear trade-offs; (3) treatment attribute preferences—patients focused on both benefits and downsides of treatment, whereas clinicians centered discussion on benefits; (4) quality of life—patients’ definition of quality of life depended on pre-HF activity, though most patients demonstrated adaptability in adjusting their daily activities to manage HF; (5) shared decision-making process—clinicians’ described a process more akin to informed consent; (6) decision support—multimedia decision aids, virtual appointments, and primary-care comanagement emerged as potential enablers of shared decision-making. CONCLUSIONS: Patients with HFrEF have several decisional needs, which are consistent with those that may respond to decision aids. These findings can inform the development of HFrEF pharmacotherapy decision aids to address these decisional needs and facilitate shared decision-making.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3